ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Alzheon to present new clinical data and analyses for ALZ-801
cphi-online
February 16, 2017The presentations highlight Alzheon’s ‘precision medicine’ approach to drug development for Alzheimer’s disease. -
Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease
pharmaasia
February 14, 2017A single nucleotide change in the DNA variant APOE4 can regulate factors influencing Alzheimer’s disease. -
Q&A on strategies for earlier diagnosis of Alzheimer’s disease – MOPEAD
lilly
February 14, 2017Defining strategies to overcome obstacles to early diagnosis and treatment in Alzheimer’s disease: MOPEAD -
New study finds benzodiazepines use increases stroke risk in people with Alzheimer’s disease
pharmaceutical-technology
January 18, 2017A new study from the University of Eastern Finland has found the use of drugs such as benzodiazepine and benzodiazepine-like drugs was related to a 20% increased risk of stroke in patients with Alzheimer’s disease. -
Selonterra Publishes Novel Proprietary Mechanism for APOE4 in Alzheimer’s Disease
b3cnewswire
January 18, 2017Selonterra LLC announced the publication of the article “Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer’s Disease” in Scientific Reports. -
New study finds antidepressant use increases hip fracture risk in people with Alzheimer’s disease
pharmaceutical-technology
January 13, 2017A new study from the University of Eastern Finland has found that the use of antidepressants nearly doubles the risk of hip fracture among community-dwelling people with Alzheimer’s disease.
Pharma Sources Insight July 2025
